Search
Milestone Pharmaceuticals Inc
MISTAdd to Watchlist
1.320USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
155.49MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
+6.45%
1 Month
+2.33%
6 Months
-35.61%
Year to Date
-34.65%
1 Year
-31.96%
Key Figures
1.320Open
1.375High
1.05MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.89%Turnover Ratio
1.320Prev. Close
1.290Low
1.04MTurnover
LossP/E Static
4.31P/B
0.00%Div Yield TTM
-53.49%ROA
3.06052wk High
1.19Volume Ratio
-41.52MNet Profit
117.79MShares
-0.6386EPS TTM
0.73Beta
-456.88%ROE
0.62552wk Low
6.44%Amplitude
94.12%Gross Margin
155.49MMarket Cap
0.51Reward/Risk
4.56%Risk Rate
TradingKey Stock Score of Milestone Pharmaceuticals Inc
Currency: USD Updated: 2026-07-02Key Insights
Milestone Pharmaceuticals Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 162 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.33.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Milestone Pharmaceuticals Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Milestone Pharmaceuticals Inc Highlights
StrengthsRisks
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 54.60% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.55M.
Fairly Valued
The company’s latest PE is -2.07, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 30.89M shares, decreasing 37.71% quarter-over-quarter.
Held by Steven Cohen
Star Investor Steven Cohen holds 921.43K shares of this stock.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
6.333
Target Price
+379.80%
Upside Space
Milestone Pharmaceuticals Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Milestone Pharmaceuticals Inc Info
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
Ticker SymbolMIST
CompanyMilestone Pharmaceuticals Inc
CEOOliveto (Joseph)
Websitehttps://www.milestonepharma.com
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Milestone Pharmaceuticals Inc (MIST)?
The current price of Milestone Pharmaceuticals Inc (MIST) is 1.32.
What is the symbol of Milestone Pharmaceuticals Inc?
The ticker symbol of Milestone Pharmaceuticals Inc is MIST.
What is the 52-week high of Milestone Pharmaceuticals Inc?
The 52-week high of Milestone Pharmaceuticals Inc is 3.06.
What is the 52-week low of Milestone Pharmaceuticals Inc?
The 52-week low of Milestone Pharmaceuticals Inc is 0.63.
What is the market capitalization of Milestone Pharmaceuticals Inc?
The market capitalization of Milestone Pharmaceuticals Inc is 155.49M.
Is Milestone Pharmaceuticals Inc (MIST) currently rated as Buy, Hold, or Sell?
According to analysts, Milestone Pharmaceuticals Inc (MIST) has an overall rating of Buy, with a price target of 6.33.
What is the Earnings Per Share (EPS TTM) of Milestone Pharmaceuticals Inc (MIST)?
The Earnings Per Share (EPS TTM) of Milestone Pharmaceuticals Inc (MIST) is -0.75.